The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Association between depression and the subsequent risk of Parkinson's disease: A meta-analysis
Abstract
Background Observational studies, including recent large cohort studies, have reported an association between depression and the risk of Parkinson's disease (PD); however, conclusions were inconsistent. Clarifying this relation might improve the understanding of risk factors for and the disease mechanisms in PD. Therefore, we performed a meta-analysis to examine whether depression is associated with an increased risk of PD. Methods A literature search in the PubMed, EMBASE, Scopus, PsycINFO and Web of Science databases was undertaken through March 2018, looking for observational studies evaluating the association between depression and the risk of PD. Pooled relative risk (RR) estimates and 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and sensitivity analyses were also performed. Results A random-effects meta-analysis of 5 cohort studies and 6 case-control studies demonstrated a significant positive association between depression and a subsequent risk of PD (RR, 2.20; 95% CI, 1.87-2.58), and it was consistent across subgroups. Furthermore, sensitivity analysis confirmed the stability of the results; visual examination of funnel plots and Begg's and Egger's tests showed no evidence of publication bias. Conclusions Our meta-analysis demonstrated that persons with depression exhibited an increased risk of a subsequent PD diagnosis. The pathophysiological and psychological mechanisms underlying this association are still unclear a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In primary care, people with schizophrenia are less likely to have had a physical examination (e.g.weight, blood pressure), 109”
From The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness (2019) · cites this paper as [109]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
Rémy, P., Doder, M., Lees, A. J., Turjanski, N., & Brooks, D. J. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,090
Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study
Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70287-x · Cited by 674
Dong, J.-Y., Zhang, Y., Tong, J., & Qin, L. (2011) · Stroke · doi:10.1161/strokeaha.111.630871 · Cited by 341
Cited by
Sorted by citations
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336
Szymkowicz, S. M., Gerlach, A., Homiack, D., & Taylor, W. D. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02464-9 · Cited by 234
The association between triglyceride glucose index and depression: data from NHANES 2005–2018
Shi, Y., Zheng, R., Cai, J., & Qian, S. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03275-2 · Cited by 150
Ahmad, M. H., Rizvi, M. M. A., Ali, M., & Mondal, A. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101840 · Cited by 141
Higher HEI-2015 Score Is Associated with Reduced Risk of Depression: Result from NHANES 2005–2016
Wang, K., Zhao, Y., Nie, J., Xu, H., Yu, C., & Wang, S. (2021) · Nutrients · doi:10.3390/nu13020348 · Cited by 137
Self-citationAssociation Between Depression and Physical Conditions Requiring Hospitalization
Frank, P., Batty, G. D., Pentti, J., Jokela, M. M., Poole, L., Ervasti, J. M., Vahtera, J., Lewis, G., Steptoe, A., & Mika Kivimaki, B. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.0777 · Cited by 131
Massey, A., Boag, M. K., Magnier, A., Bispo, D. P. C. F., Khoo, T. K., & Pountney, D. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112928 · Cited by 103
Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Dekens, D. W., Eisel, U. L. M., Gouweleeuw, L., Schoemaker, R. G., Deyn, P. P. D., & Naudé, P. J. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101414 · Cited by 93
Han, X., Hou, C., Yang, H., Chen, W., Ying, Z., Sun, Y., Qu, Y., Qu, Y., Yang, L., Valdimarsdóttir, U. A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01170-6 · Cited by 91
Optimal Treatment of Depression and Anxiety in Parkinson's Disease
Pontone, G. M., & Mills, K. A. (2021) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.02.037 · Cited by 67
Kazmi, H., Walker, Z., Booij, J., Khan, F., Shah, S., Sudre, C. H., Buckman, J. E. J., & Schrag, A. E. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324266 · Cited by 66
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population
Roos, D. S., Klein, M., Deeg, D. J. H., Doty, R. L., & Berendse, H. W. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213007 · Cited by 61
Jo, Y., Kim, S., Ye, B. S., Lee, E., & Yu, Y. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837890 · Cited by 60
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
Wang, X., Yang, J., & Hashimoto, K. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104762 · Cited by 62
Klompmaker, J. O., Laden, F., Browning, M. H. E. M., Dominici, F., Jimenez, M. P., Ogletree, S. S., Rigolon, A., Zanobetti, A., Hart, J. E., & James, P. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.47664 · Cited by 54
Non-Genetic Risk Factors for Parkinson’s Disease: An Overview of 46 Systematic Reviews
Chen, Y., Sun, X., Lin, Y., Zhang, Z., Gao, Y., & Wu, I. X. Y. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202521 · Cited by 60
Agüera-Ortíz, L., García-Ramos, R., Pérez, F. J. G., López‐Álvarez, J., Rodríguez, J. M. M., Rodríguez, F. J. O., Pueyo, J. O., Valero, C. P., & Porta-Etessam, J. (2021) · Parkinson s Disease · doi:10.1155/2021/6621991 · Cited by 44
Murayama, R., Cai, Y., Nakamura, H., & Hashimoto, K. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106209 · Cited by 44
Waddington, J. L. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0373-y · Cited by 37
Dry Eye and Phacoemulsification Cataract Surgery: A Systematic Review and Meta-Analysis
Lü, Q., Lü, Y., & Zhu, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.649030 · Cited by 35
Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial
Bradley, E., Sakai, K., Fernandes‐Osterhold, G., Szigeti, B., Ludwig, C., Ostrem, J. L., Tanner, C. M., Bock, M., Llerena, K., Finley, P. R., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02097-0 · Cited by 35
Bareeqa, S. B., Samar, S. S., Kamal, S., Masood, Y., Allahyar, Ahmed, S. I., & Hayat, G. R. (2022) · Neurodegenerative Disease Management · doi:10.2217/nmt-2022-0001 · Cited by 28
Shen, X., Gu, X. F., Liu, Y.-Y., Yang, L., Zheng, M., & Jiang, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1042522 · Cited by 31
Christodoulou, C. C., Onisiforou, A., Zanos, P., & Papanicolaou, E. Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1273855 · Cited by 27
Tufail, M. (2019) · Neurodegenerative Diseases · doi:10.1159/000506742 · Cited by 27
Ren, C., Li, L.-X., Dong, A.-Q., Zhang, Y., Hu, H., Mao, C., Wang, F., & Liu, C. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00095 · Cited by 27
Novel targets for parkinsonism-depression comorbidity
Tizabi, Y., Getachew, B., Csoka, A. B., Manaye, K. F., & Copeland, R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.004 · Cited by 25
Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models
Hayley, S. P., Vahid-Ansari, F., Sun, H., & Albert, P. R. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106115 · Cited by 24
The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
Arnaud, A. M., Suthoff, E. D., Tavares, R. M., Zhang, X., & Ravindranath, A. J. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01021-w · Cited by 21
Risk of Parkinson Disease in Individuals With Autism Spectrum Disorder
Yin, W., Reichenberg, A., Beeri, M. S., Levine, S. Z., Ludvigsson, J. F., Figee, M., & Sandin, S. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1284 · Cited by 25
Tuon, T., Meirelles, S. S., de Moura, A. B., Rosa, T., Borba, L. A., Botelho, M. E. M., Abelaira, H. M., de Mathia, G. B., Danielski, L. G., Fileti, M. E., et al. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113226 · Cited by 19
Bidirectional Mendelian randomization study of psychiatric disorders and Parkinson’s disease
Wu, Q., Liu, S., Huang, X., Liu, J., Wang, Y., Xiang, Y., Tang, X., Xu, Q., Yan, X., Tang, B., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1120615 · Cited by 20
Klompmaker, J. O., Mork, D., Zanobetti, A., Braun, D., Hankey, S., Hart, J. E., Hystad, P., Jimenez, M. P., Laden, F., Larkin, A., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108739 · Cited by 20
CSF α-synuclein correlates with CSF neurogranin in late-life depression
Bruno, D., Plaska, C. R., Clark, D. P. A., Zetterberg, H., Blennow, K., Verbeek, M. M., & Pomara, N. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1744596 · Cited by 17
Papa, D., Ingenito, A., von Gal, A., Pandis, M. F. D., & Piccardi, L. (2025) · Biomedicines · doi:10.3390/biomedicines13051023 · Cited by 17
Chen, J., Huang, Y. X., & Li, X. (2024) · Brain and Behavior · doi:10.1002/brb3.3467 · Cited by 17
Huang, C.-H., Lin, M., & Hsieh, C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.591640 · Cited by 15
The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
Basile, M. S., & Mazzon, E. (2022) · Biomedicines · doi:10.3390/biomedicines10112986 · Cited by 17
Integrated Care Models for Older Adults with Depression and Physical Comorbidity: A Scoping Review
Tops, L., Beerten, S. G., Vandenbulcke, M., Vermandere, M., & Deschodt, M. (2024) · International Journal of Integrated Care · doi:10.5334/ijic.7576 · Cited by 20
Age or age of onset: which is the best criterion to classify late-life depression?
Olgiati, P., Fanelli, G., & Serretti, A. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000472 · Cited by 13
Association between dietary flavonoid intake and depressive symptoms: A cross-sectional research
Deng, M., Liu, F., Wang, K., Zhang, M.-J., Feng, Q., & Liu, J. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.12.005 · Cited by 13
Kratter, I. H., Jorge, A., Feyder, M. T., Whiteman, A. C., Chang, Y., Henry, L. C., Karp, J. F., & Richardson, R. M. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01978-y · Cited by 13
Brazdis, R.-M., von Zimmermann, C., Lenz, B., Kornhuber, J., & Mühle, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063219 · Cited by 12
Stocchi, F., Antonini, A., Barone, P., Bellelli, G., Fagiolini, A. M., Ferini‐Strambi, L., Sorbi, S., & Padovani, A. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06740-w · Cited by 12
Bono, A. D., Twaite, J. T., Krch, D., McCabe, D. L., Scorpio, K. A., Stafford, R. J., & Borod, J. C. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-822290-4.00015-3 · Cited by 13
Cognition, motor symptoms, and glycolipid metabolism in Parkinson’s disease with depressive symptoms
Yao, C., Niu, L., Fu, Y., Zhu, X., Yang, J., Zhao, P., Sun, X., Ma, Y., Li, S., & Li, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02437-6 · Cited by 11
Heng, H., Liu, J., Hu, M., Li, D., Su, W., & Li, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1013745 · Cited by 10
Different risks of early-onset and late-onset Parkinson disease in individuals with mental illness
Yoon, S. Y., Lee, S. C., Suh, J. H., Yang, S. N., Han, K., & Kim, Y. W. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-023-00621-x · Cited by 9
Hu, W., Zhao, C.-H., Huang, Y., Liu, B.-P., & Jia, C.-X. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00810-2 · Cited by 13
Early-Life Stress Induces Prodromal Features of Parkinsonism in Ageing Rats
Ren, C., Wang, F., He, K.-J., Zhang, Y., Li, L.-X., Zhang, J., Chen, J., Mao, C., & Liu, C. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab253 · Cited by 9
Association between osteoarthritis and the incidence of Parkinson’s disease in the United Kingdom
Jacob, L., Smith, L., Koyanagi, A., Schnitzler, A., Shin, J. I., & Kostev, K. (2021) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2021.100120 · Cited by 9
Choi, K., Lee, H. J., Han, K., Koh, S., Im, J. P., & Kim, J. S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1014290 · Cited by 8
Chan, Y. E., Chen, M., Bai, Y., Li, C., Chen, T., & Su, T. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.056 · Cited by 8
Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation
Leong, I. L., Ng, T. H., Sen, K., Burchill, E., Costello, H., Badenoch, J., Coebergh, J. W. W., McCutcheon, R. A., Nair, A., Browning, M. D., et al. (2025) · Brain · doi:10.1093/brain/awaf335 · Cited by 9
Mano, M., Nomura, A., & Sasanabe, R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030914 · Cited by 7
Depressive Symptoms and the Subsequent Risk of Parkinson's Disease: A Nationwide Cohort Study
Yoon, S. Y., Heo, S., Kim, Y. W., Lee, S. C., Shin, J., & Lee, J. W. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.10.006 · Cited by 7
Rajkumar, R. P. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1455606 · Cited by 7
On the heterogeneity of depression in Parkinson’s disease
Nodel, M. R., & Yakhno, N. N. (2020) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2020-5-46-52 · Cited by 6
Prevention of Parkinson’s Disease: From Risk Factors to Early Interventions
Ng, M. G., Chan, B. J. L., Koh, R. Y., Ng, K. Y., & Chye, S. M. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230616092054 · Cited by 6
Khazai, O. F., Pishyareh, E., Rassafiani, M., Bakhshi, E., & Poursadeqiyan, M. (2019) · فصلنامه علمی پژوهشی توانبخشی · doi:10.32598/rj.20.2.190 · Cited by 6
Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease
Austgen, G., & Marsh, L. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.009 · Cited by 6
Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study
Jaakkola, E., Koponen, M., Kaasinen, V., Hietala, J. A., Hartikainen, S. A., & Tolppanen, A. (2025) · Movement Disorders · doi:10.1002/mds.70135 · Cited by 5
Hearing loss is not associated with risk of Parkinson's disease: A Mendelian randomization study
Ning, P., Mu, X. L., Guo, X., & Li, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32533 · Cited by 6
Zhu, T., Mu, D., Hu, Y., Cao, Y., Yuan, M., Xu, J., Ye, H.-Q., & Zhang, W. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03213-2 · Cited by 7
Jung, Y. J., Kim, R., Yoo, D., Han, K., & Lee, J. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01691-9 · Cited by 5
Wang, W., Wang, H., Hu, X., Yu, Q., Chen, F., Qiu, X., & Wang, X. (2025) · JMIR Public Health and Surveillance · doi:10.2196/62730 · Cited by 4
Gorbunova, A. P., Rukavishnikov, G. V., Kasyanov, E. D., & Mazo, G. E. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-5-72-78 · Cited by 4
Xiang, L., Xu, R., Zhou, X., Ren, X., Li, Z., & Wu, I. X. Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.065 · Cited by 4
Wang, M., Lu, S., Hao, L., Chen, N., & Xia, Y. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s529339 · Cited by 3
Depression is associated with the nonmotor symptoms of Parkinson's disease: A comparative analysis
Mayeli, M., Shafie, M., Shiravi, M., Parvar, T. A., Mirsepassi, Z., Rahiminejad, F., Sattarpour, R., & Aghamollaii, V. (2024) · Health Science Reports · doi:10.1002/hsr2.2106 · Cited by 3
Davydow, D. S., Okun, M. S., & Pontone, G. M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251319558 · Cited by 3
Morbidity and Associated Factors of Depressive Disorder in Patients With Parkinson's Disease
Lee, Y., Chiou, Y., Chang, Y., Hung, C., Chen, Y., Lin, T., & Wang, L. (2022) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001537 · Cited by 3
Hu, J., Wu, J., Jiang, Q., Wang, Y., Yuan, Y., Cheng, X., Li, K., Shen, Y., Zhang, J., Wang, F., et al. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.07.010 · Cited by 3
Sex Differences for Social Determinants Associated with Lewy Body Dementia Onset and Diagnosis
Bayram, E., Wyman‐Chick, K. A., Costello, R., Ghodsi, H., Rivera, C. S., Solomon, L., Kane, J. P. M., & Litvan, I. (2025) · Neurodegenerative Diseases · doi:10.1159/000544772 · Cited by 3
Depression and the risk of Parkinson’s disease: A Mendelian randomization study
Du, Y., Tang, D., Yang, G., & Xu, D. (2025) · Medicine · doi:10.1097/md.0000000000041658 · Cited by 4
Sinaeefar, M. J., Saadat, P., Hamidia, A., & Hosseini, S. R. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106549 · Cited by 3
Do we need drugs for psychiatric symptoms specifically for Parkinson's disease?
Mills, K. A., & Pontone, G. M. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251370970 · Cited by 2
Treatment Approaches To Anxiety and Depression in Parkinson’s Disease
Maruca-Sullivan, P. E., Doumlele, K., Keller, S., & Wilkins, K. M. (2025) · Current Geriatrics Reports · doi:10.1007/s13670-025-00436-z · Cited by 2
Xu, B., Liu, X., Barret, O., Tamagnan, G. D., Qiao, H., Lu, J., Zhang, C., Chan, P., & Liu, S. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70705 · Cited by 2
Clinical characteristics and risk factors of depression in prodromal Parkinson’s disease
Xu, J., Wang, Y., Li, Y., Wang, H., & Liu, W. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1708805 · Cited by 2
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2
Krämer, R. M., Moissl, A. P., Stefan Lorkowski, A., Krämer, B. K., Lehtimäki, T. J., Mishra, B. H., Mishra, P. P., Leipe, J., März, W., Kleber, M. E., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1125151 · Cited by 2
Wei, W.-X., Meng, L., Mao, Z. F., Mo, Z.-H., Yang, L., Qin, Y., & Huang, J. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1590931 · Cited by 2
Neurologic and psychiatric features of impending neurodegeneration in iRBD
Barone, D. A., Sarva, H., Hellmers, N., Wang, F., Xu, Z., Krieger, A. C., & Henchcliffe, C. (2023) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2023.100216 · Cited by 2
Do enteric glial cells play a role in the pathophysiology of major depression?
Rajkumar, R. P. (2024) · Exploration of neuroscience · doi:10.37349/en.2024.00042 · Cited by 2
Li, R., Ling, Y., Pan, A., Cao, R., Lyu, J., & Bi, W. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1440199 · Cited by 1
Sayfitdinkhuzhaev, Z. F., Жукова, Н. Г., Nasyrova, R. F., Gaponova, O. V., Zhukova, I. A., Masenko, A. Y., & Baydanova, A. N. (2026) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20261260117 · Cited by 2
Liu, D., Qi, C., Huang, J., Xie, H., Zhuang, Y., Zhang, Q., Zhao, X., Hu, T., Qin, G., Lu, Y., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70845 · Cited by 1
Gender Differences and Comorbidities in Major Depression
Jaber, M. H., Kahwaji, H., Eid, D., Atat, M. E., & Fakhoury, M. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_13 · Cited by 1
Depression in neurodegenerative disease: neurobiological mechanisms and emerging treatments
Costello, H., Reeves, S., Glue, P., Young, A. H., & Howard, R. J. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03728-8 · Cited by 1
Use of antiviral drugs and incidence of Parkinson’s disease in Taiwan
Zhang, H., Xie, J., Peng, H.-C., Lin, Y.-S., & Song, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302383 · Cited by 1
Affective disorders in Parkinson's disease
nstitute of Psychiatry "Socola", I., Alexinschi, O., Sirițeanu, E.-A., & nstitute of Psychiatry "Socola", I. (2024) · Bulletin of Integrative Psychiatry · doi:10.36219/bpi.2024.2.13 · Cited by 1
Hassan, M. S., Mohamed, N. A., Yavuz, Y., Mohamed, Y. A., & Gökgül, A. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s493161 · Cited by 1
Troubles psychiques et comportementaux
Fénelon, G., Houéto, J., & Robert, G. (2020) · Elsevier eBooks · doi:10.1016/b978-2-294-76802-6.00009-8 · Cited by 1
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: An Open-Label Pilot TrialPreprint
Bradley, E., Sakai, K., Fernandes‐Osterhold, G., Szigeti, B., Ludwig, C., Ostrem, J. L., Tanner, C. M., Bock, M., Llerena, K., Finley, P. R., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4871260 · Cited by 1
Kazmi, H. (2019) · UCL Discovery (University College London)
Kumagai, R., Kitajima, T., Hirose, M., & Iwata, N. (2020) · PubMed Central · doi:10.20407/fmj.2019-011
Metadata
- Authors
- Wang, S., Mao, S., Xiang, D., & Fang, C.
- Affiliations
- Renmin Hospital of Wuhan University (CN)
- Corresponding author
- Mao, Shanping
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 86
- Pages
- 186-192
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2806019824
- Cited by
- 128
- References
- 45
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 20 · 2023: 17 · 2022: 17 · 2021: 18 · 2020: 9 · 2019: 5
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- depression, Parkinson's disease, risk factors, neurodegeneration, disease mechanisms, cohort studies, case-control study
- MeSH terms
- Depression, Depressive Disorder, Humans, Parkinson Disease, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
